why choose us

First received: December 24, 2023

Clinical Trial: A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Severe Asthma

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center, Dose-ranging Study to Evaluate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma.The study will evaluate the incidence of asthma exacerbations, other pharmacodynamic (PD) parameters such as lung function and asthma control, and the safety and tolerability of verekitug (UPB-101) compared to placebo.

Read more